Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Abstract
The primary objective of this multi-site randomized controlled trial is to determine if receiving ACT, as compared to a control psychotherapy, is associated with reduced distress at the end of treatment. We will also examine its impact on functioning and acceptability as well as the extent to which gains are maintained after treatment. We will gather preliminary information about the impact of ACT on symptoms specific to PTSD, depression and PCS to inform future studies. In addition, we will gather information about the acceptability of and response to ACT in active duty service people as compared to those receiving care from the VA. Although the project is separately funded and administered, it is being conducted within the structure of the DoD-funded PTSD/TBI Clinical Consortium (INTRuST Consortium).
Document Details
- Document Type
- Technical Report
- Publication Date
- Nov 01, 2013
- Accession Number
- ADA600572
Entities
People
- Chad Spiegel
- David M. Benedek
Organizations
- Henry M. Jackson Foundation for the Advancement of Military Medicine